FDA oncology division taps Syapse to better incorporate real-world evidence

0
6


The organizations will collaborate on efforts to pull real-world data from a number of sources including EHRs, data registries and testing labs and determine their utility in making regulatory decisions.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here